H1N1 News and Research

RSS

Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.

Five-year program aimed at preventing future pandemic diseases awarded to DAI

DAI has been awarded a five-year program aimed at preventing future pandemics such as HIV/AIDS and H1N1.

30 Oct 2009

New online education course on H1N1 vaccination now available

mdBriefCase Inc., in collaboration with the Public Health Agency of Canada (PHAC), is pleased to provide a new online education course on H1N1 vaccination for health professionals.

30 Oct 2009

New campaign offers information and resources on seasonal and H1N1 flu prevention

Blue Cross Blue Shield of Arizona (BCBSAZ) says “Get the facts, not the flu,” in a new campaign that launches today at azblue.com/Flu. The flu campaign offers its members, employer groups and Arizona residents information and resources on seasonal and H1N1 flu prevention and immunization.

30 Oct 2009

Risk of serious flu-related sickness far outpaces risk of injectable vaccine in pregnant women

Pregnant women who catch the flu are at serious risk for flu-related complications, including death, and that risk far outweighs the risk of possible side effects from injectable vaccines containing killed virus, according to an extensive review of published research and data from previous flu seasons.

30 Oct 2009

U.S. won't donate H1N1 vaccine to developing countries until 'at-risk' Americans receive vaccine

The U.S. will hold off on donating H1N1 (swine flu) vaccine stockpiles to developing countries until "at-risk Americans" receive the vaccine, HHS Secretary Kathleen Sebelius said Wednesday, Agence France-Presse reports

30 Oct 2009

Obama administration hits reset button in wake of flu vaccine shortage

Obama administration officials are working to control the H1N1 flu message after shortages have forced many to wait for the swine flu vaccine.

29 Oct 2009

AstraZeneca bolsters revenue with Toprol-XL and H1N1 vaccine sales

AstraZeneca, Third quarter revenue increased by 10 percent at constant exchange rates (CER) to $8,200 million.

29 Oct 2009

CHU Sainte-Justine and The Montreal Children's Hospital to update the public regarding H1N1 testing at emergency rooms

The emergency rooms at the CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are seeing a significant increase in patients seeking care. The increase is due to patients with mild flu-like symptoms and fever and due to parents asking that their child be tested to determine if he has H1N1.

29 Oct 2009

Gen-Probe receives FDA emergency use authorization for its Prodesse ProFlu-ST test

Gen-Probe Incorporated today announced that the US Food and Drug Administration (FDA) has granted an EUA (emergency use authorization) for its test, the Prodesse ProFlu-ST(TM), to be used in CLIA high complexity laboratories for the diagnosis of 2009 H1N1 influenza virus infection, aided by an algorithm that relies on seasonal influenza A/H1 virus and seasonal influenza A/H3 virus results, from a single sample in individuals who are diagnosed with influenza A by currently available FDA-cleared or authorized devices.

29 Oct 2009

BioCryst Pharmaceuticals reports fiscal 2009 third-quarter results

BioCryst Pharmaceuticals, Inc. announced financial results for the quarter and nine months ended September 30, 2009 and provided a corporate update regarding clinical programs and potential emergency use of intravenous (i.v.) peramivir.

29 Oct 2009

Centene takes proactive approach to prevent influenza virus through its Fluvention program

Centene Corporation takes a proactive approach with education around how to prevent the influenza virus each year through its FluventionTM program.

29 Oct 2009

Aetna operating earnings decrease by 38% in third-quarter 2009

Aetna today announced third-quarter 2009 operating earnings of $308.2 million, or $.69 per share, a 38 percent decrease from the prior-year quarter. Operating earnings exclude net realized capital gains (losses) and other items. The decrease in operating earnings per share from the prior-year quarter reflects a lower Commercial underwriting margin and a previously announced increase in pension expense partially offset by the impact of a lower number of shares outstanding year-over-year.

29 Oct 2009

Simcere Pharmaceutical Group to control a 50.77% stake in Jiangsu Yanshen

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it has entered into an agreement to acquire a 74.49% stake in ChinaVax, a Cayman Islands company that, as its sole business, holds a 13.27% stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").

29 Oct 2009

Modern techniques can reduce current shortage of H1N1 vaccine in the U.S.

President Barack Obama declared H1N1 a national emergency this weekend, a status that will give the federal government greater flexibility and authority to contain the pandemic. But the current shortage of H1N1 vaccine underscores the severe lack of U.S. preparedness in responding to pandemics, whether through natural disease transmission or manmade bioterrorist attacks, according to a new video from the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism.

29 Oct 2009

Poison control centers to take calls for H1N1

The same reassuring voice on the telephone line when you fear you've had a poison emergency may be the same person answering your questions about the H1N1 flu pandemic.

29 Oct 2009

Comprehensive H1N1 influenza health information centre launched in Canada

Canadians are seeking credible information concerning the H1N1 (human swine flu) virus. As a leading Canadian source of ealth information, www.medbroadcast.com has launched a one-stop comprehensive national H1N1 (human swine flu) Influenza Health information centre (www.medbroadcast.com/H1N1). This information centre will help meet the needs of Canadians in search of useful, credible, and accurate H1N1 information.

29 Oct 2009

AAHP confirms homeopathic medicines for prophylaxis of infectious diseases

Recent news articles regarding Swine Flu H1N1 have been widespread. The virulence of the strain among humans and its implications for pandemic disease in humans may lead to increased interest in homeopathic treatments for Swine Flu H1N1.

29 Oct 2009

Pregnant women with symptoms of depression have a stronger biological reaction to the seasonal flu vaccine

Pregnant women with significant symptoms of depression tend to have a stronger biological reaction to the seasonal flu vaccine than do women with lower depression levels, according to a new study.

29 Oct 2009

GE Healthcare to provide surveillance data for H1N1 and seasonal influenza activity throughout the U.S.

GE Healthcare, one of the leading providers of healthcare information technology, today announced its selection by the Centers for Disease Control and Prevention (CDC) to provide extensive surveillance data for H1N1 and seasonal influenza activity throughout the United States.

29 Oct 2009

Insurer stocks rise after Reid's 'opt-out' announcement

A day after Senate Majority Leader Harry Reid proposed an 'opt-out' public option plan, health-care insurers' stocks climbed Tuesday," Dow Jones Newswires/The Wall Street Journal reports.

28 Oct 2009

H1N1 News and Research

Five-year program aimed at preventing future pandemic diseases awarded to DAI

New online education course on H1N1 vaccination now available

New campaign offers information and resources on seasonal and H1N1 flu prevention

Risk of serious flu-related sickness far outpaces risk of injectable vaccine in pregnant women

U.S. won't donate H1N1 vaccine to developing countries until 'at-risk' Americans receive vaccine

Obama administration hits reset button in wake of flu vaccine shortage

AstraZeneca bolsters revenue with Toprol-XL and H1N1 vaccine sales

CHU Sainte-Justine and The Montreal Children's Hospital to update the public regarding H1N1 testing at emergency rooms

Gen-Probe receives FDA emergency use authorization for its Prodesse ProFlu-ST test

BioCryst Pharmaceuticals reports fiscal 2009 third-quarter results

Centene takes proactive approach to prevent influenza virus through its Fluvention program

Aetna operating earnings decrease by 38% in third-quarter 2009

Simcere Pharmaceutical Group to control a 50.77% stake in Jiangsu Yanshen

Modern techniques can reduce current shortage of H1N1 vaccine in the U.S.

Poison control centers to take calls for H1N1

Comprehensive H1N1 influenza health information centre launched in Canada

AAHP confirms homeopathic medicines for prophylaxis of infectious diseases

Pregnant women with symptoms of depression have a stronger biological reaction to the seasonal flu vaccine

GE Healthcare to provide surveillance data for H1N1 and seasonal influenza activity throughout the U.S.

Insurer stocks rise after Reid's 'opt-out' announcement

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News